IL6 and breast cancer: Reduced triple-negative breast cancer cell viability, invasion, and mammosphere formation; induced apoptosis; downregulated IL-6/JAK/STAT3 and EMT pathways; reduced tumor volume and weight in mouse breast cancer patient-derived cells xenograft